$4.6B Biovail Suit Attacks Shorting By Hedge Funds
Canada's largest pharmaceutical company, Biovail Corporation, has filed a $4.6 billion lawsuit against 22 institutional and individual investors, alleging that powerful hedge funds conspired with Wall Street analysts in a plot...To view the full article, register now.
Already a subscriber? Click here to view full article